“一带一路”国家黄热病输入我国的风险评估  

Risk assessment of yellow fever importation from “The Belt and Road” countries into China

作　　者：王亚丽[1] 周蕾[1] 任瑞琦 黎丹[1] 李超[1] 施国庆[1] 张彦平[1] Wang Yali;Zhou Lei;Ren Ruiqi;Li Dan;Li Chao;Shi Guoqing;Zhang Yanping(Public Health Emergency Center,Chinese Center for Disease Control and Prevention,Beijing 102206,China)

机构地区：[1]中国疾病预防控制中心卫生应急中心,北京102206

出　　处：《疾病监测》2021年第6期534-538,共5页Disease Surveillance

基　　金：国家科技重大专项(No.2018ZX10101002-003)。

摘　　要：根据世界卫生组织官方网站、文献、媒体等报道的相关资料,对黄热病输入我国的风险和输入后的扩散风险进行定性评估认为,黄热病输入我国的风险持续存在,但输入风险和输入后在本地传播的风险均较低。针对持续存在的输入风险和输入后可能的继发传播风险,要进一步加强我国赴“一带一路”疫情国家旅行人员黄热病疫苗接种和防蚊等知识的宣传教育,并加强归国人员的卫生检疫和对黄热病等新发传染病的监测力度,持续开展蚊媒监测和控制,防范疫情输入和输入后进一步传播。Qualitative risk assessments of importation and further spread of yellow fever in China were conducted based on data from WHO website, literature and media information. The results indicated that the importation risk of yellow fever into China still exists, but the risks of both importation and local transmission are low. In view of the risks of the persistent importation and possible further transmission of yellow fever in China, it is necessary to strengthen the vaccination of yellow fever and health education about mosquito repelling for travelers from China to yellow fever endemic countries of “The Belt and Road”. It is essential to strengthen the health quarantine of returnees from these countries and surveillance for new infectious diseases, such as yellow fever, and continue the monitoring and control of mosquito vectors to prevent the importation and further transmission of yellow fever in China.

关 键 词：黄热病 输入 蚊媒控制 疫苗接种 风险评估 传播 

分 类 号：R211[医药卫生—中医学] R511